HUT34212A - Process for the production of new vindblastin conjugates - Google Patents
Process for the production of new vindblastin conjugatesInfo
- Publication number
- HUT34212A HUT34212A HU841610A HU161084A HUT34212A HU T34212 A HUT34212 A HU T34212A HU 841610 A HU841610 A HU 841610A HU 161084 A HU161084 A HU 161084A HU T34212 A HUT34212 A HU T34212A
- Authority
- HU
- Hungary
- Prior art keywords
- conjugates
- new
- image
- vindblastin
- production
- Prior art date
Links
- -1 acetylamino- Chemical class 0.000 abstract 2
- 150000001412 amines Chemical class 0.000 abstract 2
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 abstract 1
- 235000008206 alpha-amino acids Nutrition 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004185 ester group Chemical group 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 102000035118 modified proteins Human genes 0.000 abstract 1
- 108091005573 modified proteins Proteins 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
- 229960003048 vinblastine Drugs 0.000 abstract 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6805—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Cephalosporin Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU84784A LU84784A1 (fr) | 1983-04-29 | 1983-04-29 | Nouveaux conjugues proteiques de la vinblastine leur procede de preparation et leur utilisation therapeutique |
| LU85161A LU85161A1 (fr) | 1983-12-29 | 1983-12-29 | Nouveaux conjugues de la vinblastine,leur procede de preparation et leur utilisation therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUT34212A true HUT34212A (en) | 1985-02-28 |
Family
ID=26640299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU841610A HUT34212A (en) | 1983-04-29 | 1984-04-26 | Process for the production of new vindblastin conjugates |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4870162A (cg-RX-API-DMAC10.html) |
| EP (1) | EP0124502B1 (cg-RX-API-DMAC10.html) |
| AT (1) | ATE64396T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU575819B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA1234800A (cg-RX-API-DMAC10.html) |
| DE (1) | DE3484691D1 (cg-RX-API-DMAC10.html) |
| DK (1) | DK210784A (cg-RX-API-DMAC10.html) |
| ES (1) | ES8600769A1 (cg-RX-API-DMAC10.html) |
| GR (1) | GR81790B (cg-RX-API-DMAC10.html) |
| HU (1) | HUT34212A (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ207992A (cg-RX-API-DMAC10.html) |
| OA (1) | OA07711A (cg-RX-API-DMAC10.html) |
| PT (1) | PT78508B (cg-RX-API-DMAC10.html) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE57187T1 (de) * | 1983-03-30 | 1990-10-15 | Lilly Industries Ltd | Vincaleukoblastin-derivate. |
| GB2181126B (en) * | 1983-03-30 | 1987-08-26 | Lilly Industries Ltd | Novel pharmaceutical compounds |
| LU86157A1 (fr) * | 1985-11-12 | 1987-06-26 | Omnichem Sa | Nouveau procede de fabrication de conjugues de la vinblastine et de ses derives |
| US4675400A (en) * | 1985-06-17 | 1987-06-23 | Eli Lilly And Company | Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids |
| US4667030A (en) * | 1985-06-17 | 1987-05-19 | Eli Lilly And Company | Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids |
| FR2584293B1 (fr) * | 1985-07-04 | 1989-03-17 | Ire Celltarg Sa | Anticorps utiles comme agents de pilotage et conjugues les incorporant |
| ATE89567T1 (de) * | 1985-11-12 | 1993-06-15 | Wallone Region | Konjugate von vinblastin und seine derivate, verfahren zur herstellung derselben und diese konjugate enthaltende pharmazeutische zusammensetzungen. |
| EP0232693A3 (fr) * | 1985-12-16 | 1988-04-06 | La Region Wallonne | Conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques les contenant |
| FR2608158B2 (fr) * | 1986-12-12 | 1992-03-27 | Ire Celltarg Sa | Nouveaux derives de vinblastine et composition pharmaceutique les contenant |
| US4801688A (en) * | 1986-05-27 | 1989-01-31 | Eli Lilly And Company | Hydrazone immunoglobulin conjugates |
| US4728183A (en) * | 1986-10-01 | 1988-03-01 | Ocular Instruments, Inc. | Ophthalmic lens for observing the fundus of the eye |
| FR2626882B1 (fr) * | 1988-02-08 | 1991-11-08 | Ire Celltarg Sa | Conjugues de derives de vinca comportant une chaine detergente en position c-3 |
| US5322678A (en) * | 1988-02-17 | 1994-06-21 | Neorx Corporation | Alteration of pharmacokinetics of proteins by charge modification |
| US5144012A (en) * | 1988-08-08 | 1992-09-01 | Eli Lilly And Company | Cytotoxic drug conjugates |
| US5094849A (en) * | 1988-08-08 | 1992-03-10 | Eli Lilly And Company | Cytotoxic antibody conjugates of hydrazide derivatized vinca analogs via simple organic linkers |
| US5006652A (en) * | 1988-08-08 | 1991-04-09 | Eli Lilly And Company | Intermediates for antibody-vinca drug conjugates |
| US5007729A (en) * | 1989-10-27 | 1991-04-16 | Ocular Instruments, Inc. | Wide angle ophthalmic lens |
| US5189450A (en) * | 1991-05-21 | 1993-02-23 | Ocular Instruments, Inc. | High magnification ophthalmic lens |
| US5309187A (en) * | 1992-03-18 | 1994-05-03 | Ocular Instruments, Inc. | High magnification ophthalmic lens |
| US5789189A (en) * | 1993-09-24 | 1998-08-04 | The Regents Of The University Of California | Inhibition of cyst formation by cytoskeletal specific drugs |
| EP1350523B1 (en) * | 1992-09-25 | 2007-05-16 | Boston Scientific Limited | Therapeutic conjugates inhibiting vascular smooth muscle cells |
| US6143864A (en) * | 1994-06-28 | 2000-11-07 | Merck & Co., Inc. | Peptides |
| US5866679A (en) * | 1994-06-28 | 1999-02-02 | Merck & Co., Inc. | Peptides |
| US5962216A (en) * | 1994-08-19 | 1999-10-05 | La Region Wallonne | Tumor-activated prodrug compounds and treatment |
| US5623323A (en) * | 1994-10-26 | 1997-04-22 | Ocular Instruments, Inc. | Extra wide field ophthalmic lens |
| US5998362A (en) * | 1996-09-12 | 1999-12-07 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| US5948750A (en) * | 1996-10-30 | 1999-09-07 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| US6127333A (en) * | 1997-07-10 | 2000-10-03 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| US6391305B1 (en) | 1997-09-10 | 2002-05-21 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| ZA9810974B (en) * | 1997-12-02 | 1999-06-03 | Merck & Co Inc | Conjugates useful in the treatment of prostate cancer |
| EP1036093A1 (en) * | 1997-12-02 | 2000-09-20 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| US20040081659A1 (en) * | 1997-12-02 | 2004-04-29 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| AU5240999A (en) * | 1998-07-31 | 2000-02-21 | Goldsmith Seeds Inc. | Trimeric and polymeric alkaloids |
| US6174858B1 (en) * | 1998-11-17 | 2001-01-16 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| US7425541B2 (en) | 1998-12-11 | 2008-09-16 | Medarex, Inc. | Enzyme-cleavable prodrug compounds |
| GB0012718D0 (en) * | 2000-05-24 | 2000-07-19 | Angeletti P Ist Richerche Bio | Conjugates of aminodrugs |
| AU6685301A (en) | 2000-06-14 | 2001-12-24 | Corixa Corp | Prodrug compounds with isoleucine |
| US20030232760A1 (en) * | 2001-09-21 | 2003-12-18 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| US20040022727A1 (en) * | 2002-06-18 | 2004-02-05 | Martin Stanton | Aptamer-toxin molecules and methods for using same |
| US7767803B2 (en) | 2002-06-18 | 2010-08-03 | Archemix Corp. | Stabilized aptamers to PSMA and their use as prostate cancer therapeutics |
| US8853376B2 (en) | 2002-11-21 | 2014-10-07 | Archemix Llc | Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| ES2395082T3 (es) * | 2003-01-27 | 2013-02-08 | Endocyte, Inc. | Conjugado de folato-vinblastina como medicamento |
| US20050148534A1 (en) * | 2003-09-22 | 2005-07-07 | Castellino Angelo J. | Small molecule compositions and methods for increasing drug efficiency using compositions thereof |
| WO2006012527A1 (en) | 2004-07-23 | 2006-02-02 | Endocyte, Inc. | Bivalent linkers and conjugates thereof |
| WO2006096754A2 (en) * | 2005-03-07 | 2006-09-14 | Archemix Corp. | Stabilized aptamers to psma and their use as prostate cancer therapeutics |
| ES2468240T3 (es) * | 2005-08-19 | 2014-06-16 | Endocyte, Inc. | Conjugados de ligando de múltiples fármacos |
| WO2007022493A2 (en) * | 2005-08-19 | 2007-02-22 | Endocyte, Inc. | Ligand conjugates of vinca alkaloids, analogs, and derivatives |
| WO2008101231A2 (en) | 2007-02-16 | 2008-08-21 | Endocyte, Inc. | Methods and compositions for treating and diagnosing kidney disease |
| NZ580132A (en) | 2007-03-14 | 2012-11-30 | Endocyte Inc | Binding ligand linked drug delivery conjugates of tubulysins to vitamins |
| US9877965B2 (en) | 2007-06-25 | 2018-01-30 | Endocyte, Inc. | Vitamin receptor drug delivery conjugates for treating inflammation |
| JP5690589B2 (ja) | 2007-06-25 | 2015-03-25 | エンドサイト・インコーポレイテッドＥｎｄｏｃｙｔｅ， Ｉｎｃ． | 親水性スペーサーリンカーを含有する結合体 |
| US10080805B2 (en) | 2012-02-24 | 2018-09-25 | Purdue Research Foundation | Cholecystokinin B receptor targeting for imaging and therapy |
| US20140080175A1 (en) | 2012-03-29 | 2014-03-20 | Endocyte, Inc. | Processes for preparing tubulysin derivatives and conjugates thereof |
| IN2015DN04147A (cg-RX-API-DMAC10.html) | 2012-10-16 | 2015-10-16 | Endocyte Inc |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1037379A (en) * | 1965-01-11 | 1966-07-27 | Lilly Co Eli | Desacetyl polynuclear indoles |
| FR2349335A1 (fr) * | 1976-04-28 | 1977-11-25 | Inst Int Pathologie Cellulaire | Complexes d'alcaloides bis-indoliques du type vinblastine avec la tubuline, leur procede d'obtention et leur utilisation |
| US4096148A (en) * | 1976-12-06 | 1978-06-20 | Eli Lilly And Company | Oxazolidinedione derivatives of Vinca alkaloids |
| US4357334A (en) * | 1980-03-20 | 1982-11-02 | Eli Lilly And Company | Use of VLB 3-(2-chloroethyl) carboxamide in treating neoplasms |
| OA06421A (fr) * | 1980-06-10 | 1981-09-30 | Omnium Chimique Sa | Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides. |
| LU83822A1 (fr) * | 1981-12-08 | 1983-09-01 | Omnichem Sa | Derives n-(vinblastinoyl-23)d'acides amines,leur preparation et leur application therapeutique |
| FI820020A7 (fi) * | 1981-01-12 | 1982-07-13 | Lilly Industries Ltd | Immunoglobuliinikonjugaatteja. |
| ATE57187T1 (de) * | 1983-03-30 | 1990-10-15 | Lilly Industries Ltd | Vincaleukoblastin-derivate. |
| US4522750A (en) * | 1984-02-21 | 1985-06-11 | Eli Lilly And Company | Cytotoxic compositions of transferrin coupled to vinca alkaloids |
| US4801688A (en) * | 1986-05-27 | 1989-01-31 | Eli Lilly And Company | Hydrazone immunoglobulin conjugates |
-
1984
- 1984-04-26 EP EP84870057A patent/EP0124502B1/fr not_active Expired - Lifetime
- 1984-04-26 AT AT84870057T patent/ATE64396T1/de active
- 1984-04-26 GR GR74519A patent/GR81790B/el unknown
- 1984-04-26 HU HU841610A patent/HUT34212A/hu unknown
- 1984-04-26 DE DE8484870057T patent/DE3484691D1/de not_active Expired - Lifetime
- 1984-04-27 AU AU27434/84A patent/AU575819B2/en not_active Ceased
- 1984-04-27 ES ES531965A patent/ES8600769A1/es not_active Expired
- 1984-04-27 OA OA58284A patent/OA07711A/xx unknown
- 1984-04-27 PT PT78508A patent/PT78508B/pt not_active IP Right Cessation
- 1984-04-27 DK DK210784A patent/DK210784A/da not_active Application Discontinuation
- 1984-04-30 NZ NZ207992A patent/NZ207992A/en unknown
- 1984-04-30 CA CA000453143A patent/CA1234800A/en not_active Expired
-
1986
- 1986-04-23 US US06/854,909 patent/US4870162A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES531965A0 (es) | 1985-11-01 |
| EP0124502A3 (en) | 1986-05-07 |
| AU2743484A (en) | 1984-11-01 |
| US4870162A (en) | 1989-09-26 |
| NZ207992A (en) | 1987-04-30 |
| EP0124502A2 (fr) | 1984-11-07 |
| AU575819B2 (en) | 1988-08-11 |
| EP0124502B1 (fr) | 1991-06-12 |
| CA1234800A (en) | 1988-04-05 |
| PT78508A (en) | 1984-05-01 |
| DE3484691D1 (de) | 1991-07-18 |
| DK210784A (da) | 1984-10-30 |
| DK210784D0 (da) | 1984-04-27 |
| ATE64396T1 (de) | 1991-06-15 |
| GR81790B (cg-RX-API-DMAC10.html) | 1984-12-12 |
| OA07711A (fr) | 1985-06-30 |
| ES8600769A1 (es) | 1985-11-01 |
| PT78508B (en) | 1986-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT34212A (en) | Process for the production of new vindblastin conjugates | |
| NO930006L (no) | Fremgangsmaate ved fremstilling av beta-laktamer | |
| GR3030722T3 (en) | Improved synthesis of bisindolylmaleimides. | |
| EP0291981A3 (en) | Cyclic anticoagulant peptides | |
| AU1634288A (en) | Cyclic anticoagulant peptides | |
| AU580350B2 (en) | Process for synthesising peptides | |
| FI925260A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 6-amino-substituoitujen oktahydro-1,7,8-indolitsiinitriolijohdannaisten valmistamiseksi | |
| AU531708B2 (en) | Bis thymosine alpha-1 compounds | |
| HUT42493A (en) | Process for producing new conjugates and derivatives of vinblastine and pharmaceutical compositions containing them | |
| NZ215994A (en) | Culturing e.coli to produce interferon alpha and gamma and interleukin-2 | |
| EP0144750A3 (en) | Antibiotics, method for their preparation, their use as medicines and intermediates for their preparation | |
| ES447686A1 (es) | Procedimiento para la preparacion de tripeptidos derivados de la l-prolina. |